Lineage Inc. investors may be eligible for a class action lawsuit settlement.

A lawsuit has been filed on behalf of Lineage, Inc. (NASDAQ: LINE) shareholders who purchased shares in or traceable to the company's July 26, 2024 initial public offering. The complaint alleges that Lineage issued false and/or misleading statements about sustained weakening in customer demand and additional cold-storage supply. Shareholders who purchased during this period are encouraged to contact the firm regarding possible lead plaintiff appointment.

Lineage Inc. (NASDAQ: LINE) shareholders who purchased shares in or traceable to the company's July 2024 initial public offering (IPO) are being urged to file a lead plaintiff motion in a securities fraud lawsuit. The lawsuit alleges that Lineage made materially false and/or misleading statements and failed to disclose adverse facts about the company's business, operations, and prospects.

The class action lawsuit, filed on behalf of investors, claims that Lineage failed to disclose sustained weakening in customer demand and the increased availability of cold-storage supply. These factors led to a significant decrease in Lineage's revenue, occupancy rates, and rent prices. The complaint also alleges that Lineage implemented price increases before the IPO that could not be sustained due to the weakening demand environment.

Shareholders are encouraged to contact Glancy Prongay & Murray LLP or The Gross Law Firm to inquire about the possibility of being appointed as a lead plaintiff. The deadline to file a lead plaintiff motion is September 30, 2025.

Lineage's stock price has remained substantially below its IPO price since the complaint was filed. In July 2024, Lineage sold over 65 million shares of common stock at $78 per share. However, the company's stock price fell significantly after reporting poor financial results and layoffs due to reduced customer demand.

The lawsuit is being pursued to recover losses incurred by shareholders who purchased or otherwise acquired Lineage common stock pursuant and/or traceable to the IPO.